Format

Send to

Choose Destination
J Dig Dis. 2019 Apr 10. doi: 10.1111/1751-2980.12752. [Epub ahead of print]

Metastatic mixed acinar-neuroendocrine carcinoma of pancreas treated with multidisciplinary team: A case report and brief review of the literature.

Author information

1
Department of Medical Oncology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
2
Department of Radiation Oncology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
3
Department of Hepatobiliary and Pancreatic Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
4
Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, Zhejiang Province, China.
5
Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, Chinese National Ministry of Education; Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.

Abstract

Ranked the fourth or fifth most common cause of cancer globally, pancreatic cancer is recognized as "the king of cancer" for the high malignant potential (1). Pancreatic cancer develops from either the endocrine (islet cell) or exocrine (ductal or acinar cell) systems of the pancreas, and which can be categorized accordingly into three types: ductal, acinar or endocrine.

PMID:
30972937
DOI:
10.1111/1751-2980.12752

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center